News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
194,970 Results
Type
Article (14020)
Company Profile (23)
Press Release (180927)
Multimedia
Podcasts (9)
Webinars (5)
Section
Business (54385)
Career Advice (615)
Deals (10655)
Drug Delivery (30)
Drug Development (29562)
Employer Resources (70)
FDA (5148)
Job Trends (4229)
News (100877)
Policy (8861)
Tag
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1084)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (31)
Alliances (15064)
ALS (37)
Alzheimer's disease (445)
Antibody-drug conjugate (ADC) (22)
Approvals (5165)
Artificial intelligence (60)
Autoimmune disease (8)
Automation (3)
Bankruptcy (74)
Best Places to Work (3371)
BIOSECURE Act (6)
Biosimilars (34)
Biotechnology (11)
Bladder cancer (20)
Brain cancer (9)
Breast cancer (82)
Cancer (580)
Cardiovascular disease (61)
Career advice (516)
Career pathing (13)
CAR-T (45)
Cell therapy (116)
Cervical cancer (9)
Clinical research (25148)
Collaboration (180)
Compensation (27)
Complete response letters (1)
COVID-19 (1090)
CRISPR (8)
C-suite (60)
Cystic fibrosis (21)
Data (736)
Denatured (6)
Depression (9)
Diabetes (98)
Diagnostics (1779)
Digital health (4)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (37)
Drug pricing (38)
Drug shortages (16)
Duchenne muscular dystrophy (31)
Earnings (16789)
Editorial (16)
Employer branding (5)
Employer resources (64)
Events (23266)
Executive appointments (212)
FDA (5490)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (201)
Gene editing (17)
Generative AI (6)
Gene therapy (84)
GLP-1 (270)
Government (1207)
Grass and pollen (1)
Guidances (12)
Healthcare (5666)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (30)
Indications (7)
Infectious disease (1135)
Inflammatory bowel disease (52)
Inflation Reduction Act (4)
Influenza (14)
Intellectual property (17)
Interviews (104)
IPO (3945)
IRA (19)
Job creations (989)
Job search strategy (454)
Kidney cancer (2)
Labor market (6)
Layoffs (82)
Leadership (7)
Legal (1943)
Liver cancer (23)
Lung cancer (64)
Lymphoma (41)
Machine learning (1)
Management (23)
Manufacturing (70)
MASH (32)
Medical device (3371)
Medtech (3373)
Mergers & acquisitions (6871)
Metabolic disorders (221)
Multiple sclerosis (38)
NASH (15)
Neurodegenerative disease (21)
Neuropsychiatric disorders (4)
Neuroscience (627)
NextGen: Class of 2025 (2039)
Non-profit (1640)
Northern California (522)
Now hiring (1)
Obesity (101)
Opinion (48)
Ovarian cancer (18)
Pain (31)
Pancreatic cancer (20)
Parkinson's disease (55)
Partnered (7)
Patents (31)
Patient recruitment (33)
Peanut (17)
People (19111)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5641)
Phase II (10729)
Phase III (10188)
Pipeline (304)
Policy (53)
Postmarket research (1294)
Preclinical (2024)
Press Release (30)
Prostate cancer (36)
Psychedelics (9)
Radiopharmaceuticals (72)
Rare diseases (107)
Real estate (1497)
Recruiting (23)
Regulatory (6344)
Reports (18)
Research institute (908)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (19)
Schizophrenia (24)
Series A (48)
Series B (29)
Service/supplier (2)
Sickle cell disease (12)
Southern California (505)
Special edition (2)
Spinal muscular atrophy (63)
Sponsored (4)
Startups (1250)
Stomach cancer (4)
Supply chain (15)
Tariffs (6)
The Weekly (3)
United States (5032)
Vaccines (281)
Venture capitalists (8)
Weight loss (69)
Women's health (14)
Worklife (6)
Date
Today (25)
Last 7 days (117)
Last 30 days (634)
Last 365 days (8706)
2025 (2441)
2024 (9159)
2023 (10540)
2022 (15318)
2021 (16565)
2020 (15759)
2019 (14455)
2018 (11159)
2017 (10526)
2016 (10130)
2015 (12213)
2014 (8430)
2013 (6478)
2012 (6926)
2011 (7206)
2010 (6285)
Location
Africa (263)
Alabama (8)
Alaska (4)
Arizona (42)
Arkansas (2)
Asia (13054)
Australia (2464)
California (1223)
Canada (385)
China (145)
Colorado (52)
Connecticut (51)
Delaware (36)
Europe (44005)
Florida (170)
Georgia (71)
Idaho (14)
Illinois (149)
India (10)
Indiana (86)
Iowa (3)
Japan (65)
Kansas (30)
Kentucky (7)
Louisiana (5)
Maine (11)
Maryland (233)
Massachusetts (895)
Michigan (38)
Minnesota (83)
Missouri (18)
Montana (6)
Nebraska (6)
Nevada (17)
New Hampshire (10)
New Jersey (454)
New Mexico (7)
New York (480)
North Carolina (214)
Northern California (522)
Ohio (38)
Oklahoma (3)
Oregon (5)
Pennsylvania (321)
Puerto Rico (3)
Rhode Island (4)
South America (395)
South Carolina (7)
Southern California (505)
Tennessee (17)
Texas (147)
Utah (21)
Virginia (38)
Washington D.C. (6)
Washington State (164)
Wisconsin (10)
194,970 Results for "avacta group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
March 27, 2025
·
3 min read
Press Releases
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
March 10, 2025
·
2 min read
Press Releases
Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update
March 10, 2025
·
6 min read
Press Releases
Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives
April 1, 2025
·
4 min read
Press Releases
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
October 15, 2024
·
3 min read
Press Releases
Avacta Appoints Brian Hahn as Chief Financial Officer
January 14, 2025
·
3 min read
Press Releases
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
March 7, 2025
·
5 min read
Press Releases
Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers
January 16, 2025
·
6 min read
Press Releases
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
October 21, 2024
·
4 min read
Drug Development
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
Avacta Group plc announces that the first patient has been dosed in the US under its Investigational New Drug (IND) Application in Avacta’s phase 1 multi-centre trial evaluating the safety and tolerability of AVA6000, a novel tumour targeted form of doxorubicin and Avacta’s first therapeutic product based on its proprietary pre|CISION™ technology.
April 27, 2023
·
1 min read
1 of 19,497
Next
